Terms of Use
Click here to read the terms of use on which you may make use of the website www.boehringer-ingelheim.com/in, whether as a visitor or a registered user.
Search
COVID-19: EFPIA Industry Information
The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
It’s Your Heart. Protect It. The Podcast.
In season 2, we hear from a range of experts to explore further how the interconnected systems call for collaboration and approach to care. Learn more.
COVID-19 Q&A for Patients
Corona and COVID-19 can lead to many questions. We want to answer a few of them, provide some general information and give some recommendations.
Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
Protecting Animals and Humans
At Boehringer Ingelheim we are committed to ensuring the continued availability of our products for patients, customers and animals during the pandemic.
Chronic Kidney Disease
Chronic kidney disease affects approximately 850 million people worldwide which is more than ten percent of the population.
NexGard Spectra launched in China
Early August 2018, NexGard Spectra (afoxolaner and milbemycin oxime), the first oral endectocide for dogs, was launched in China. Click here to learn more.
COVID-19 Volunteering in Canada
Colleagues across Canada are doing their part during the pandemic by supporting their community’s needs. Click here to find out and learn more information.
COVID-19 USA U.S. employees show gratitude #foreachother
Employees across the U.S. display Boehringer Ingelheim’s culture of caring during this challenging time. Click here to find out and learn more.
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.
Cat care interview veterinarian Dr Susan Little
We interviewed world-renowned feline healthcare specialist Dr Susan Little to get her thoughts on cat care. Click here to read and find out more.
World Patient Safety Day 2021
As a sign of support for World Patient Safety Day, Boehringer Ingelheim lights up buildings in orange. Click here to learn and find out more.
History
Learn about the history of Boehringer Ingelheim, starting with Albert Boehringer founding the company in 1885 when it employed just 28 people.
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach is a herculean task – but also an innovation that carries huge potential. Learn more here.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.
COVID-19 India - supporting community during the pandemic
Boehringer Ingelheim India was amongst the first few companies supporting local authorities in Maharashtra in this crisis. Click here to learn more.
Stroke Risk Factors Symptoms
Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Find out more about risk factors and symptoms.
Travelling with dogs
What are some of the things we should consider when traveling with dogs? Click here to read our tips for a relaxing trip with your furry companion.
World Heart Day 2021
The heart is one of the things with the potential to unite all of us as people. Click here to read patient stories about their heartbeat moment.
Expectations towards our business partners
Boehringer Ingelheim utilises an extensive network of international suppliers. Click here to learn more about our expectations towards our suppliers.
COVID-19 Volunteering in Australia and New Zealand
Our employees down under have embraced the opportunity to volunteer their time and skills as part of the company’s COVID-19 Global Support Program.
COVID-19 Germany Together through the Pandemic
Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.
REACH / GHS / Material safety data sheets
European and international chemical legislations like REACH and GHS impact Boehringer Ingelheim's activities in many different ways. Learn more here.